Clinical Trials Logo

Clinical Trial Summary

Blushing is associated with a heightened self-focused attention. In our study we are interested if this self-focused attention can be shown experimentally and if it can be changed by therapy and training. For the experimental part of the study, we want to compare blushing fearful individuals to social anxious participants who are not fearful of blushing and to healthy controls who report to blush either seldom or quite often. In the therapeutical part of our study, we compare an attention training to the standard cognitive behavioral therapy for social anxiety disorder in an intensive group therapy approach.


Clinical Trial Description

Fear of blushing is a specific syndrome in social anxiety disorder. Although attentional biases for social anxiety disorders have often been reported, specific data for fear of blushing are still missing. In this study, dysfunctional attention processes are examined by the use of various questionnaire measures and attention tests (e.g. Stroop test, task switching paradigm) comparing fear of blushers, other social phobia patients, healthy volunteers who report to blush seldomly respectively often. The second goal of the study is to examine if these attention processes can be changed by training and therapy. Therefore, individuals who fulfill DSM-IV criteria for social anxiety disorder and report fear of blushing as main problem, are treated with attention training and with CBT for social anxiety disorder. Therapy will be held in the form of intensive weekend group therapy. Differences in outcomes for both therapy types and in changeability of attention processes on objective test data are examined. Stability of results are tested up to 6-month and 12-month after post-assessment. ;


Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00751465
Study type Interventional
Source Technische Universität Dresden
Contact
Status Completed
Phase N/A
Start date November 2008
Completion date December 2010

See also
  Status Clinical Trial Phase
Completed NCT02590770 - Gaze Contingent Feedback in Social Anxiety Disorder N/A
Completed NCT03630783 - Combined CBM For Social Anxiety in Turkey N/A
Terminated NCT00182533 - Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Phase 4
Completed NCT01470469 - SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) Phase 2
Not yet recruiting NCT05649059 - Investigating the Effects of Cannabidiol on Social Anxiety Disorder Phase 4
Completed NCT01557894 - Internet Treatment for Social Phobia in Romania N/A